Those with aging immune systems struggle to fight off novel viruses and respond weakly to vaccination. Stanford Medicine researchers were able to revitalize the immune system in mice.

A drug that binds to allergy-causing antibodies can protect children from dangerous reactions to accidentally eating allergy-triggering foods, a Stanford Medicine-led study found.

Children’s noses pack a punch that could help explain COVID-19’s typically mild course in young kids. Researchers hope to parlay that ‘nasal magic’ into increased protections for adults.

A drug that boosts strength in injured or aging mice restores connections between nerves and muscle and suggests ways to combat weakness in humans due to aging, injury or disease.

In a study led by Stanford Medicine researchers, a low-cost COVID-19 vaccine that does not require refrigeration provided immunity in rhesus monkeys for one year.

Stanford Medicine researchers have shown that prior SARS-CoV-2 infection reduces killer T cells’ response to vaccination. These cells are crucial for eliminating the virus from the body.

A connection found between asthma, eczema and osteoarthritis indicates that drugs to treat allergic conditions could be used in future studies aimed at slowing the progression of osteoarthritis.

A novel Stanford School of Medicine partnership uncovers a direct link between a cancer-associated gene, Myc, and sugar patterns on cancer cell surfaces that tell immune cells to stand down.

Developing the right treatment for long COVID depends on figuring out what’s causing it. Stanford Medicine researchers are bent on learning more about the people who have it to find out.

Researchers found that when they turned cancer cells into immune cells, they were able to teach other immune cells how to attack cancer.